Market closedNon-fractional
Instil Bio/TIL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Instil Bio
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Ticker
TIL
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Dallas, United States
Employees
49
Website
instilbio.com
Instil Bio Metrics
BasicAdvanced
$64M
Market cap
-
P/E ratio
-$18.96
EPS
1.18
Beta
-
Dividend rate
Price and volume
Market cap
$64M
Beta
1.18
Financial strength
Current ratio
14.187
Quick ratio
13.62
Long term debt to equity
40.873
Total debt to equity
41.69
Interest coverage (TTM)
-11.65%
Management effectiveness
Return on assets (TTM)
-13.01%
Return on equity (TTM)
-47.71%
Valuation
Price to book
0.29
Price to tangible book (TTM)
0.29
Price to free cash flow (TTM)
-0.87
Growth
Earnings per share change (TTM)
-45.60%
3-year earnings per share growth
-28.94%
What the Analysts think about Instil Bio
Analyst Ratings
Majority rating from 3 analysts.
Instil Bio Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$24M
88.37%
Profit margin
0.00%
NaN%
Instil Bio Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$2.80
-$10.40
-$1.99
-$3.74
-
Expected
-$3.27
-$2.00
-$2.85
-$2.23
-$2.98
Surprise
-14.29%
420.00%
-30.05%
67.71%
-
Instil Bio News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Instil Bio stock?
Instil Bio (TIL) has a market cap of $64M as of July 06, 2024.
What is the P/E ratio for Instil Bio stock?
The price to earnings (P/E) ratio for Instil Bio (TIL) stock is 0 as of July 06, 2024.
Does Instil Bio stock pay dividends?
No, Instil Bio (TIL) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Instil Bio dividend payment date?
Instil Bio (TIL) stock does not pay dividends to its shareholders.
What is the beta indicator for Instil Bio?
Instil Bio (TIL) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Instil Bio stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.